Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-Bromo-3-fluorophenylene-1,2-diamine and 3,4-Diamino-2-fluorobromobenzene are both aromatic amine compounds with unique structural features. 4-Bromo-3-fluorophenylene-1,2-diamine is a diamine compound characterized by the presence of bromine and fluorine substituents on a phenylene ring. In contrast, 3,4-Diamino-2-fluorobromobenzene is a substituted benzene compound featuring amino, fluorine, and bromine groups. These chemical compounds serve as important building blocks in the synthesis of various products across different industries.

886762-86-3

Post Buying Request

886762-86-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 4-Bromo-3-fluorophenylene-1,2-diamine, 3,4-Diamino-2-fluorobromobenzene

    Cas No: 886762-86-3

  • USD $ 1.9-2.9 / Gram

  • 100 Gram

  • 1000 Metric Ton/Month

  • Chemlyte Solutions
  • Contact Supplier

886762-86-3 Usage

Uses

Used in Pharmaceutical Industry:
4-Bromo-3-fluorophenylene-1,2-diamine is used as a key intermediate in the synthesis of pharmaceuticals and organic compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Dye and Pigment Industry:
3,4-Diamino-2-fluorobromobenzene is utilized in the production of dyes and pigments. Its distinct chemical properties contribute to the creation of vibrant colors and stable pigments for various applications.
Used in Organic Synthesis:
Both 4-Bromo-3-fluorophenylene-1,2-diamine and 3,4-Diamino-2-fluorobromobenzene are employed in organic synthesis as valuable building blocks. Their versatile structures enable the development of a wide range of organic compounds with diverse applications in various industries.

Check Digit Verification of cas no

The CAS Registry Mumber 886762-86-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,6,7,6 and 2 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 886762-86:
(8*8)+(7*8)+(6*6)+(5*7)+(4*6)+(3*2)+(2*8)+(1*6)=243
243 % 10 = 3
So 886762-86-3 is a valid CAS Registry Number.

886762-86-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-bromo-3-fluorobenzene-1,2-diamine

1.2 Other means of identification

Product number -
Other names 4-bromo-3-fluoro-benzene-1,2-diamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:886762-86-3 SDS

886762-86-3Relevant articles and documents

Immunomodulator

-

Paragraph 0131-0132; 0135, (2021/05/22)

The invention discloses an immunomodulator, and particularly relates to a compound for inhibiting IL-17A and application of the compound serving as the immunomodulator in preparation of drugs. The invention discloses application of a compound shown in a f

POLYCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND OR THE COMPOSITION

-

Page/Page column 365, (2020/11/03)

Specific polycyclic compounds, a material for an organic electroluminescence device comprising said specific polycyclic compound, an organic electroluminescence device comprising said specific polycyclic compound, an electronic equipment comprising said organic electroluminescence device, a process for preparing said polycyclic compounds, and the use of said polycyclic compounds in an organic electroluminescence. (Formula I) (I)

PYRIDIN-2-ONE DERIVATIVES OF FORMULA (II) USEFUL AS EP3 RECEPTOR ANTAGONISTS

-

, (2019/02/24)

The present invention is directed to pyridin-2-one derivatives, pharmaceutical compositions containing them and their use as antagonists of the EP3 receptor, for the treatment of for example, impaired oral glucose tolerance, elevated fasting glucose, Type II Diabetes Mellitus, Syndrome X (also known as Metabolic Syndrome) and related disorders and complications thereof.

PYRIDIN-2-ONE DERIVATIVES OF FORMULA (III) USEFUL AS EP3 RECEPTOR ANTAGONISTS

-

, (2019/02/24)

The present invention is directed to pyridin-2-one derivatives, pharmaceutical compositions containing them and their use as antagonists of the EP3 receptor, for the treatment of for example, impaired oral glucose tolerance, elevated fasting glucose, Type II Diabetes Mellitus, Syndrome X (also known as Metabolic Syndrome) and related disorders and complications thereof.

PYRIDIN-2-ONE DERIVATIVES OF FORMULA (I) USEFUL AS EP3 RECEPTOR ANTAGONISTS

-

, (2019/02/24)

The present invention is directed to pyridin-2-one derivatives, pharmaceutical compositions containing them and their use as antagonists of the EP3 receptor, for the treatment of for example, impaired oral glucose tolerance, elevated fasting glucose, Type II Diabetes Mellitus, Syndrome X (also known as Metabolic Syndrome) and related disorders and complications thereof.

SERINE/THREONINE PAK1 INHIBITORS

-

, (2013/03/26)

Compounds having the formula I wherein A, Z, R1a, R1b, R2, R3, R4, R5, R6, R7, R9, R10, Ra, Rb and n are as defined herein are inhibitors of PAK1. Also disclosed are compositions and methods for treating cancer and hyperproliferative disorders.

ANTI-VIRAL COMPOUNDS

-

, (2012/06/30)

Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.

NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS

-

Page/Page column 90, (2010/09/07)

This invention relates to novel compounds which are antagonists or inverse agonists at one or more of the opioid receptors, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 886762-86-3